Pfizer to seek OK for COVID-19 vaccine in November
Nearly all planned 44,000 participants enrolled in final-stage trial. If found safe, vaccine could see use in November.
Full Article
Pfizer to seek OK for COVID-19 vaccine in November
CBS News
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
-
Pfizer hopes to produce 100mln COVID-19 vaccine doses before 2021
Proactive Investors
-
US stocks close sharply lower as coronavirus deal deadline looms
Proactive Investors
Advertisement
More coverage
Dow Jones, S&P 500 and Nasdaq advanced as Pfizer announced that could have a coronavirus vaccine ready
Invezz
Concerns about sluggish economic growth amid the ongoing pandemic continue to dominate the financial markets. According to the..
-
Markets give back early gains as coronavirus deal deadline looms
Proactive Investors
-
Coronavirus Vaccine: Pfizer Says It Won't Seek Authorization Before Mid-November
NYTimes.com
-
US benchmarks get off to good start as hopes rise for agreed stimulus package
Proactive Investors
-
Coronavirus vaccine: Pfizer CEO discusses COVID-19 vaccine by end of November possibly
Upworthy